9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
21 hedge funds and large institutions have $1.37M invested in 9 Meters Biopharma in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
11% more funds holding
Funds holding: 19 → 21 (+2)
51% less capital invested
Capital invested by funds: $2.81M → $1.37M (-$1.44M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$58.4K |
| 2 |
HWA
Heritage Wealth Advisors
Richmond,
Virginia
|
+$25K |
| 3 |
VF
Virtu Financial
New York
|
+$19K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$15.8K |
| 5 |
BlackRock
New York
|
+$13.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$256K |
| 2 |
Morgan Stanley
New York
|
-$52.3K |
| 3 |
Bank of New York Mellon
New York
|
-$16K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.58K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$4K |
NMTR Hedge Fund Activity: Q4 2019 in Review
21 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q4 2019, worth a combined $1.37M — down 51% from $2.81M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NMTR positions and 3 closed out — a net gain of 2 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $58.4K. The largest seller was Sabby Management, cutting an estimated $256K.
- 21 institutional investors held 9 Meters Biopharma (NMTR) as of Q4 2019, up from 19 in Q3 2019.
- Funds reported $1.37M of 9 Meters Biopharma stock for Q4 2019, down 51% quarter-over-quarter.
- 5 funds opened new 9 Meters Biopharma positions in Q4 2019 and 3 closed out, a net change of +2 holders.
- The largest 9 Meters Biopharma buyer in Q4 2019 was Renaissance Technologies, an estimated $58.4K added.
- The largest 9 Meters Biopharma seller in Q4 2019 was Sabby Management, an estimated $256K sold.
Based on aggregated 13F filings for Q4 2019.